KC-0937

MCF7-ARO Cell Line

×
21251
Home » Cell Lines » MCF7-ARO Cell Line

Background of MCF7-ARO Cell Line

ARO encodes aromatase, a cytochrome P450 enzyme that catalyzes the final steps of estrogen biosynthesis from androgen precursors. Aromatase activity is central to estrogen production and is an established therapeutic target in hormone-dependent breast cancer.

Specifications

Catalog NumberKC-0937
Cell Line NameMCF7-ARO Cell Line
NCBI/UniProt Accession NumberNM_000103.4
Host Cell LineHuman MCF7 cell line
DescriptionStable MCF7 cell line overexpressing exogenous human ARO (aromatase)
QuantityOne vial of frozen cells (≥2×106 cells)
StabilityStable in culture over a minimum of 10 passages
ApplicationDrug screening and biological assays
Freezing Medium70% EMEM + 20% FBS + 10% DMSO
Propagation MediumEMEM + 10% FBS + 1 μg/mL Puromycin + 0.01 mg/mL insulin
Selection MarkerPuromycin
MorphologyEpithelial
SubcultureSplit at a ratio of 1:2–1:4 every 3–4 days
Incubation37 °C with 5% CO₂
StorageLiquid nitrogen immediately upon receiving
Doubling TimeEstimated 36–96 hours
Mycoplasma StatusNegative
In Vivo ValidationNA

Cell Line Generation

MCF7-ARO cell line was generated using a lentiviral vector expressing the human ARO sequence.

Characterization

Figure 1: Characterization of ARO (aromatase) overexpression in the MCF7-ARO stable cell line using Western blot.

Figure 2: Characterization of the ARO sequence in the MCF7-ARO stable cell line using Sanger sequencing.

Cell Resuscitation

  1. Pre-warm complete culture medium (basal medium and 10% FBS) in a 37°C water bath.
  2. Rapidly thaw the cryovial in a 37°C water bath for 1-2 minutes with gentle agitation.
  3. Transfer the vial to a biosafety cabinet, and disinfect the exterior with 70% ethanol.
  4. Aseptically transfer the cell suspension dropwise into a sterile centrifuge tube containing 9.0 mL of pre-warmed complete medium.
  5. Centrifuge at approximately 125 × g for 5–7 minutes at room temperature, carefully aspirate the supernatant without disturbing the cell pellet.
  6. Gently resuspend the pellet in an appropriate volume of complete medium and transfer the suspension into a T25 flask.
  7. Incubate the flask in a 37°C in a humidified 5% CO₂ incubator.
  8. Assess cell viability and morphology after 24 hours. If cells appear healthy, replace the medium with fresh medium supplemented with the appropriate selective antibiotic.
  9. Subculture the cells at a ratio of 1:2-1:4 every 3-4 days upon reaching 80%–90% confluency.

Cell Freezing

  1. Prepare the freezing medium (70% basal medium, 20% FBS and 10% DMSO) freshly before use.
  2. Pre-chill the freezing medium on ice and label the cryovials accordingly.
  3. Transfer the cell suspension to a sterile conical tube and perform a cell count to determine total viability and density.
  4. Centrifuge the cells at 250×g for 5 minutes at room temperature; carefully aspirate the supernatant.
  5. Gently resuspend the pellet in chilled freezing medium, ensuring a minimum cell density of 3×10⁶ cells/mL.
  6. Aliquot 1 mL of the cell suspension into each pre-labeled cryovial.
  7. Place the cryovials into a CoolCell® container and store at -80°C overnight for controlled-rate cooling.
  8. Transfer the cryovials to the liquid nitrogen for long-term storage the following day.

References

  1. Simpson ER, Clyne C, Rubin G, et al. Aromatase--a brief overview. Annu Rev Physiol. 2002;64:93-127.
  2. Simpson ER, Dowsett M. Aromatase and its inhibitors: significance for breast cancer therapy. Recent Prog Horm Res. 2002;57:317-338.
  3. Barros-Oliveira MC, Costa-Silva DR, Dos Santos AR, et al. Influence of ARO gene expression levels in women with breast cancer: a systematic review of the literature. Clinics (Sao Paulo). 2021;76:e2846.

Use License Agreement

Research Use Only.
Not for use in diagnostic procedures or therapeutic applications.
Redistribution of the cell line or its derivatives is prohibited without prior written permission from Kyinno Biotechnology.